Hydrocortisone Teva Uk (Hydrocortisone)

Hydrocortisone Teva UK is prescribed for conditions that require systemic glucocorticoid therapy. It is used when clinicians need to replace deficient cortisol or to reduce inflammation in various disorders.

• Management of primary or secondary adrenal insufficiency
• Treatment of severe allergic reactions or anaphylaxis when oral therapy is appropriate
• Control of inflammatory autoimmune diseases such as rheumatoid arthritis
• Adjunct therapy for certain dermatologic conditions requiring systemic treatment
• Short‑term use in acute exacerbations of chronic obstructive pulmonary disease (COPD)

• Hydrocortisone acts as an agonist at intracellular glucocorticoid receptors, binding to the receptor complex and translocating to the nucleus. This interaction modulates gene transcription, leading to decreased production of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation. The overall effect reduces inflammation and alters the body’s stress response, mimicking the action of endogenous cortisol.

Oral hydrocortisone may cause a range of adverse reactions, from mild to potentially serious. Patients should be aware of common symptoms and seek medical attention for any serious signs.

Common

• Increased appetite or weight gain
• Fluid retention causing mild swelling
• Mood changes such as irritability or anxiety
• Elevated blood glucose levels, especially in diabetics
• Gastrointestinal discomfort or nausea

Serious

• Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing
• Signs of infection, including fever and chills
• Uncontrolled hypertension or cardiovascular events
• Osteoporosis or bone fractures with long‑term use
• Adrenal suppression leading to crisis on abrupt discontinuation

Before starting Hydrocortisone Teva UK, patients should consider several safety factors to minimize risks.

• Assess for active infections; avoid initiating therapy if untreated bacterial, viral, or fungal infection is present
• Evaluate blood glucose and blood pressure regularly, especially in patients with diabetes or hypertension
• Use the lowest effective dose for the shortest duration to reduce risk of osteoporosis and adrenal suppression
• Monitor for signs of psychiatric effects, such as mood swings or depression
• Caution in patients with a history of peptic ulcer disease or gastrointestinal bleeding
• Discuss pregnancy and lactation status with a healthcare provider, as safety data are limited

Hydrocortisone can interact with several medications, altering its effectiveness or increasing adverse effects.

Avoid

• Strong CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine) that may reduce hydrocortisone levels
• Live vaccines, because systemic steroids can diminish immune response
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) combined with high‑dose steroids, increasing risk of gastrointestinal bleeding

Use with caution

• Anticoagulants such as warfarin, as steroids may affect clotting parameters
• Antidiabetic agents, since hydrocortisone can raise blood glucose
• Antihypertensive drugs, because fluid retention may counteract blood pressure control
• Other immunosuppressants, which may amplify infection risk
• Diuretics, potentially worsening electrolyte imbalances